Melvin Lee Kiang Chua

Presentation
Plasma EBV DNA is the archetypal biomarker for endemic Nasopharyngeal Carcinoma (NPC). In my lecture, I will discuss on the utility of plasma EBV DNA for screening, baseline stratification, on treatment response monitoring and treatment adaptation, and disease surveillance.

Bio
Dr. Chua a Clinician-Scientist at the National Cancer Centre Singapore (NCCS) and the Duke-NUS Medical School. He is the Head of Department and Senior Consultant for the Department of Head and Neck and Thoracic Radiation Oncology, Principal Investigator of the Precision Radiotherapeutics and Oncology Programme (PROP) (www.chualabnccs.com); and Director of the Data and Computational Science Hub at NCCS. He is currently Associate Professor (On Tenure) of Duke-NUS Medical School, Singapore; and Visiting Professor of the Zhongnan Hospital of Wuhan University, China.